JSC R-PHARM — Bevacizumab Importer Profile
Pharmaceutical Importer · #1 buyer for Bevacizumab · $2.5M import value · 51 shipments · RUSSIA · DGFT Verified
JSC R-PHARM is the #1 importer of Bevacizumab from India with $2.5M in import value and 51 verified shipments. JSC R-PHARM holds a 5.4% market share in Bevacizumab imports based in RUSSIA. The company sources from 1 verified supplier across 28 formulations shipped to 1 country. Overall, JSC R-PHARM imports 2 pharmaceutical products worth $3.9M across 1 therapeutic categories.
JSC R-PHARM — Bevacizumab Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Bevacizumab to JSC R-PHARM?
Verified from 51 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $2.5M | 51 | 100.0% |
JSC R-PHARM sources Bevacizumab from 1 verified Indian supplier based on 51 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 100.0% of imports.
How Does JSC R-PHARM Compare to Nearest Bevacizumab Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | JSC R-PHARM ★ | RUSSIA | $2.5M | 51 | $50.0K |
| 7 | SEAN DOMINICAN SRL | DOMINICAN REPUBLIC | $1.0M | 30 | $33.6K |
| 5 | DR.REDDYS LABORATORIES SAS | COLOMBIA | $1.0M | 20 | $50.0K |
JSC R-PHARM ranks #1 among 346 Bevacizumab importers from India. Average shipment value of $50.0K compared to the market average of $24.2K. The closest competitors by value are SEAN DOMINICAN SRL and DR.REDDYS LABORATORIES SAS.
Where Does JSC R-PHARM Import Bevacizumab To?
Destination countries from 51 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $2.5M | 51 | 100.0% |
JSC R-PHARM imports Bevacizumab to 1 country. The primary destination is RUSSIA receiving 100.0% of shipments worth $2.5M.
What Bevacizumab Formulations Does JSC R-PHARM Import?
| Formulation | Value | Shipments |
|---|---|---|
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CO | $1.1M | 22 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 34.0 MG/ML WITH BUFFER SOLUTION 28,404 L(QTY:965.736 GMS) | $100.0K | 2 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 28,040 L(QTY:1009.440 GMS) | $100.0K | 2 |
| BEVACIZUMAB WCB(QTY:2 VIALS)(NET WEIGHT:2 GMS) | $50.0K | 1 |
| BEVACIZUMAB WCB(WORKING CELL BANK)(QTY:3VIALS) | $50.0K | 1 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 33.0 MG/ML WITH BUFFER SOLUTION 26,284 L(QTY:867.372 GMS) | $50.0K | 1 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 33.0 MG/ML WITH BUFFER SOLUTION 27,050 L(QTY:892.650 GMS) | $50.0K | 1 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 34.0 MG/ML WITH BUFFER SOLUTION 25,207 L(QTY:857.038 GMS) | $50.0K | 1 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 28,142 L(QTY:1013.112 GMS) | $50.0K | 1 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 33.0 MG/ML WITH BUFFER SOLUTION 28,906 L(QTY:953.898 GMS) | $50.0K | 1 |
JSC R-PHARM imports 28 distinct Bevacizumab formulations from India. The top formulation is BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CO with 22 shipments worth $1.1M.
Who Are the Top Buyers of Bevacizumab from India and How Much Does JSC R-PHARM Import?
India exported $8.4M worth of Bevacizumab through 1,408 shipments from 196 suppliers to 100 countries, serving 346 buyers globally. JSC R-PHARM imports $2.5M of this total, accounting for 5.4% of India's Bevacizumab exports with 51 shipments from RUSSIA. This is verified from 51 customs shipment records covering 28 distinct formulations.
What Is the Average Order Value for JSC R-PHARM's Bevacizumab Imports?
JSC R-PHARM's average Bevacizumab order value is $50.0K per consignment, based on 51 shipments totaling $2.5M. JSC R-PHARM is based in RUSSIA and ranks #1 among all Bevacizumab importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Bevacizumab to JSC R-PHARM?
JSC R-PHARM sources Bevacizumab from 1 verified Indian supplier: DR.REDDY'S LABORATORIES LIMITED ($2.5M, 100.0%). This is based on 51 customs records.
How Does JSC R-PHARM Compare to Other Bevacizumab Importers?
JSC R-PHARM ranks #1 among 346 Bevacizumab importers from India with a 5.4% market share. The top 3 importers are JSC R-PHARM ($2.5M), SEAN DOMINICAN SRL ($1.0M), DR.REDDYS LABORATORIES SAS ($1.0M). JSC R-PHARM processed 51 shipments from RUSSIA.
What Other Advanced Oncology Products Does JSC R-PHARM Import?
JSC R-PHARM also imports these advanced oncology products. Each links to the detailed product page.
About JSC R-PHARM
JSC R-PHARM imports 2 products worth $3.9M. Beyond Bevacizumab, top products include Rituximab. View the complete JSC R-PHARM profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bevacizumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bevacizumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: JSC R-PHARM matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as JSC R-PHARM's capped import value divided by total capped export value for Bevacizumab across all Indian exporters.
- 5.Verified Records: This page is backed by 51 individual customs records matching JSC R-PHARM importing Bevacizumab, covering 28 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 346+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bevacizumab Import Data for JSC R-PHARM
Access order-level details, pricing data, supplier connections, and competitive analysis for JSC R-PHARM's Bevacizumab imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JSC R-PHARM
Full Company Profile →
2 products · $3.9M total trade · 1 categories
JSC R-PHARM × Bevacizumab
Verified from customs records
Company Overview
Top Products by JSC R-PHARM
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for JSC R-PHARM.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bevacizumab. For current order-level data, contact TransData Nexus.